| Name | Title | Contact Details |
|---|
Custom Granular is a Genoa City, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Envision Healthcare is on the front lines of change. Through our primary business units – Envision Physician Services, Evolution Health and AMSURG – our clinician-led organization is changing the face of healthcare by delivering high-quality care that elevates the patient experience. Envision Healthcare is pioneering solutions to the toughest challenges in healthcare. We serve as a partner to help navigate the constantly evolving landscape of healthcare delivery, and we are vigilant in working with health systems and hospitals to identify opportunities to better serve our communities. Our physicians, advanced practice providers and support teams are responsible for more than 30 million annual patient encounters across the U.S. Learn more about how we care for patients here.MISSION Our mission is to improve the patient experience and public health while reducing the cost of available healthcare per capita. As the largest provider of physician services to hospital and health systems through Envision Physician Services, we are committed to supporting our hospital and health system partners in delivering local, high-quality care. COMMUNITIES Our employees are committed to supporting the communities we serve by providing charitable donations. Our time is dedicated to helping our communities remain safe, active, healthy and productive by getting involved and giving back.
WorkCompEDI, Inc. is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
American Geological Institute is a Alexandria, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.